Leaked documents from the Trans Pacific Partnership (TPP) Agreement negotiations currently underway in Peru show the US is seeking to use the agreement to increase the monopoly rights of pharmaceutical companies and undermine the effectiveness of pharmaceutical reimbursement programs like Australia’s Pharmaceutical Benefits Scheme.
The TPP is a proposed regional trade agreement involving Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, the United States and Vietnam.
The texts, leaked over the weekend, include an annex on ‘transparency and procedural fairness for healthcare technologies’ and extra provisions for an intellectual property rights chapter that was leaked in February this year — via redwolf.newsvine.com
Share this Story
RSS – Posts